Carboxylesterase 1 (Ces1): From monocyte marker to major player

Journal of Clinical Pathology

Volumn 64, Issue 2, 2011, Pages 107-109

  Markey, Geraldine M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLESTERASE; ARYLESTERASE; CAPECITABINE; CARBOXYLESTERASE; CARBOXYLESTERASE 1; CELL MARKER; COCAINE; CYCLOSARIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESTERASE; METHYLPHENIDATE; ORGANOPHOSPHATE; OSELTAMIVIR; UNCLASSIFIED DRUG;

CELL KILLING; ENZYME ANALYSIS; ENZYME HISTOCHEMISTRY; HEMATOLOGY; HUMAN; IMMUNOSURVEILLANCE; LEUKEMIA; MONOCYTE; PHARMACOLOGY; PRIORITY JOURNAL; REVIEW; TOXICOLOGY; TUMOR CELL;

BIOLOGICAL MARKERS; CARBOXYLIC ESTER HYDROLASES; CELL DEATH; HUMANS; MONOCYTES; MUTATION; NEOPLASMS; PHARMACEUTICAL PREPARATIONS;

EID: 79151471906     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2010.084657     Document Type: Review

References (42)

1. Braunstein H. Esterase in leucocytes. J Histochem Cytochem 1958;7:202.
2. Yam LT, Li CY, Crosby WH. Cytochemical identification of monocytes and granulocytes. Amer J Clin Path 1971;55:283-90.
3. Li CY, Lam KW, Yam LT. Esterases in human leukocytes. J Histochem Cytochem 1973;21:1-12.
4. Radzun HJ, Parwaresch MR, Kulenkamph C, et al. Lysosomal acid esterase activity and isoenzymes in separated normal human blood cells. Blood 1980;55:891-7.
5. Gignac SM, Drexler HG. Monocyte-specific esterase isoenzyme demonstrated by isoelectric focusing. Electrophoresis 1990;11:819-24.
6. Radzun HJ, Parwaresch MR, Wittke JW. Polymorphism and antigenic specificity of monocytic acid esterase (EC 3.1.1.6). Cell Immunol 1981;63:400-8.
7. Soman J, Kaplow LS. Monocyte contamination in ficoll-hypaque mononuclear cell concentrates. J Immunol Meth 1980;32:215-21.
8. Lee ML, Waters HC 3rd. Inhibition of monocyte esterase activity by organophosphate insecticides. Blood 1977;50:947-51.
9. Oemichen M, Pedal I, Besserer K, et al. Inhibition of non-specific leukocyte esterase activity. Absence of monocyte esterase activity due to phosphoric and thiophosphoric acid ester intoxication. Forensic Sci Int 1984;25:181-9.
10. Emmett EA, Lewis PG, Tanaka F, et al. Industrial exposure to organophosphorus compounds. Studies of a group of workers with a decrease in esterase-staining monocytes. J Occup Med 1985;27:905-14. (Pubitemid 16208479)
11. Hemmert AC, Otto TC, Wierdl M, et al. Human carboxylesterase 1 stereoselectively binds the nerve agent cyclosarin and spontaneously hydrolyses the nerve agent sarin. Mol Pharmacol 2010;77:508-16.
12. Redinbo MR, Bencharit S, Potter PM. Human carboxylesterase1: from drug metabolism to drug discovery. Biochem Soc Trans 2003;31:620-4.
13. Oertel J, Hagner G, Kastner M, et al. The relevance of a-naphthyl acetate esterases to various monocyte functions. Br J Haematol 1985;61:717-26.
14. McCormick JA, Markey GM, Morris TCM, et al. Lactoferrin inducible cytotoxicity defective in esterase deficient monocytes. Br J Haematol 1991;77:287-90.
15. Sokol RJ, Hudson G, Wales JM, et al. Abnormalities of esterase and glycogen in developing macrophages in non-Hodgkin's lymphoma: a quantitative cytochemical study. Anal Cell Pathol 1995;8:297-306.
16. Burgaleta C, Villalba S, Gonzalez MS. Defective activity of monocytes from patients with Non-Hodgkin's lymphoma. Cancer 1999;86:2133-7.
17. Markey GM, McCormick JA, Morris TCM, et al. Monocyte esterase deficiency in malignant neoplasia. J Clin Pathol 1990;43:282-6.
18. Markey GM, Curry RC, Swain D, et al. Monocyte esterase deficiency in gastrointestinal cancer. J Clin Pathol 1993;46:529-32.
19. Markey GM, Alexander HD, McConnell R, et al. Hereditary monocyte esterase deficiency. Br J Haematol 1986;63:359-62.
20. Markey GM, Morris TCM, Alexander HD, et al. Monocyte esterase? a factor involved in the pathogenesis of lymphoproliferative neoplasia. Leukemia 1987;1:236-9.
21. Bell AL, Markey GM, McCaigue MD, et al. Heredofamilial deficiency of monocyte esterase in patients with rheumatoid arthritis. Ann Rheum Dis 1992;51:668-70.
22. Hull DR, Corr BR, Markey GM, et al. Familiality of monocyte esterase deficiency in patients on continuous ambulatory peritoneal dialysis. Ren Failure 1998;20:607-12.
23. Newcombe DS. Immune surveillance, organophosphorus exposure and lymphomagenesis. Lancet 1992;339:539-41.
24. Zschunke F, Salmassi A, Kreipe H, et al. cDNA cloning and characterization of human monocyte/macrophage serine esterase-1 (HMSE1). Blood 1991;78:506-12.
25. Munger JS, Shi GP, Mark EA, et al. A serine esterase released by human alveolar macrophages is closely related to liver microsomal carboxylesterases. J Biol Chem 1991;266:18832-8.
26. Orr NJ. Characterisation Of Monocyte Esterase Deficiency: PhD Thesis, The Queen's University of Belfast; Chapter 2: Molecular genetics of CES 1, 2004:59.
27. Fukami T, Nakajima FT, Maruichi T, et al. Structure and characterization of human carboxylesterase 1A1, 1A2 and 1A3 genes. Pharmacogenet Genomics 2008;18:911-20.
28. Bencharit S, Morton CL, Xue Y, et al. Structural basis of heroin and cocaine metabolism by a promiscuous human drug-processing enzyme. Nat Struct Biol 2003;10:577-83.
29. Sun Z, Murry DJ, Sanghani S, et al. Methylphenidate is stereoselectively hydrolysed by human carboxylesterase CES1A1. J Pharm Exp Ther 2004;310:469-76.
30. Brzezinski MR, Spink BJ, Dean RA, et al. Human liver carboxylesterase hCE1: binding specificity for cocaine, heroin and their metabolites and analogs. Drug Metab Dispos 1997;25:1089-96.
31. Tabata T, Katoh M, Tokudome S, et al. Identification of the cytosolic carboxylesterase catalysing the 5′-deoxy-5-fluorocytidine formation from capecitabine in human liver. Drug Metab Dispos 2004;32:1103-10.
32. Geshi E, Kimura T, Yoshimura M, et al. A single nucleotide polymorphism in the carboxylesterase gene is associated with the responsiveness to imidapril medication and the promoter activity. Hypertens Res 2005;28:719-25.
33. Zhu HJ, Appel DL, Johnson JA, et al. Role of carboxylesterase 1 and impact of natural genetic variants on the hydrolysis of trandolapril. Biochem Pharmacol 2009;77:1266-72.
34. Shi D, Yang J, Jang D, et al. Anti-influenza prodrug oseltamivir is activated by carboxylesterase human carboxylesterase 1 and the activation is inhibited by antiplatelet agent clopidogrel. J Pharmacol Exp Ther 2006;319:1477-84.
35. Zhu HJ, Patrick KS, Yuan HJ, et al. Two CES1 gene mutations lead to dysfunctional carboxylesterase1 activity in man: clinical significance and molecular basis. Am J Hum Genet 2008;82:1241-8.
36. Nemoda Z, Angyal N, Tarnok Z, et al. Carboxylesterase1 gene polymorphism and methylphenidate response in ADHD. Neuropharmacol 2009;57:731-3.
37. Kojima A, Hackett NR, Crystal RG. Reversal of CPT-11 resistance of lung cancer cells by adenovirus-mediated gene transfer of the human carboxylesterase cDNA. Cancer Res 1998;58:4368-74.
38. Kojima A, Hackett NR, Ohwada A, et al. In-vivo human carboxylesterase cDNA gene transfer to activate the prodrug CPT-11 for local trearment of solid tumors. J Clin Invest 1998;101:1789-96.
39. Orr NJ. Characterisation Of Monocyte Esterase Deficiency: PhD Thesis, The Queen's University of Belfast; Chapter 4: MED and Irinotecan metabolism, 2004:113.
40. Humerickhouse R, Lohrbach K, Li L, et al. Characterization of CPT-11 hydrolysis by human liver carboxylesterase isoforms hCE1 and hCE2. Cancer res 2000;60:1189-92.
41. Wierdl M, Tsurkan L, Hyatt JL, et al. An improved human carboxylesterase for enzyme/prodrug therapy with CPT-11. Cancer Gene Ther 2008;15:183-92.
42. Satoh T, Hemmerlein B, Zschunke F, et al. In situ detection of human monocyte/macrophage serine esterase 1 mRNA expression in human tissues. Pathobiology 1999;67:158-62.